eNose in Head and Neck Cancer.

Smellprints in lung Cancer; The role of ENose in diagnosis and Treatment (SCENT). Part 4: Diagnostic value of the eNose in Head and Neck Cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21851

Enrollment

Registered

2010-07-22

Start date

2010-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer oropharynx carcinoma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients (18-80 yr) with histologic confirmed oral and orofaryngeal squamous cell carcinoma. Healthy controls, matched with the head and neck cancer for sex, age and smoking status. Inclusion criteria: 1. Written informed consent obtained; 2. Head and neck cancer: A. Adult 18-80 years; B. Head and neck cancer of oral and oropharyngeal area; C. Histology: squamous cell carcinoma. 3. Controls, matched for: A. Age: 3 months; ii. Current smoker or ex-smoker < 3 months; C. Sex.

Exclusion criteria

Exclusion criteria: 1. Periodontitis; 2. Consumption of alcohol in last 48 hours; 3. Any infection (especially of the airways) in the last 4 weeks; 4. Other known pulmonary disease; 5. Other or former malignancy; 6. Diabetes mellitus (documented in the past); 7. Pregnancy; 8. Untreated hypercholesterolaemia (documented in the past); 9. Significant cardiovascular disease (documented in the past).

Design outcomes

Primary

Measure	Time frame
Breathprint of electronic nose.	—

Contacts

Public ContactJ. Maten, van der

Dept. of pulmonary diseases MCL Leeuwarden

j.maten@znb.nl+31 (0)58 286 6190

Outcome results